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Abstract 
Ovariectomized animal models have been extensively used in osteoporosis research due 
to the resulting loss of bone mass. The purpose of the present study was to test the 
hypothesis that estrogen depletion alters mineralization regulation mechanisms in an 
ovariectomized monkey animal model. To achieve this we used Raman 
microspectroscopy to analyze humeri from monkeys that were either SHAM-operated or 
ovariectomized (N=10 for each group). Measurements were made as a function of tissue 
age and cortical surface (periosteal, osteonal, endosteal) based on the presence of calcein 
fluorescent double labels. 
In the present work we focused on osteoid seams (defined as a surface with evident 
calcein labels, 1µm distance away from the mineralizing front, and for which the Raman 
spectra showed the presence of organic matrix but not mineral), as well as the youngest 
mineralized tissue between the second fluorescent label and the mineralizing front, 1µm 
inwards from the front with the phosphate mineral peak evident in the Raman spectra 
(TA1). The spectroscopically determined parameters of interest were the relative 
glycosaminoglycan (GAG) and pyridinoline (Pyd) contents in the osteoid, and the mineral 
content in TA1. 
At all three cortical surfaces, significant correlations were evident in the SHAM-operated 
animals between osteoid GAG (negative) and Pyd content, and mineral content, unlike 
the OVX animals.  
These results suggest that in addition to the well-established effects on turnover rates and 
bone mass, estrogen depletion alters the regulation of mineralization by GAGs and Pyd.  
Keywords: Estrogen, glycosaminoglycans, pyridinoline, Raman spectroscopy, bone 
formation, osteoporosis 
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Introduction 
 Estrogen is the most important systemic regulator of bone metabolism in both women 
and men [1-3]. It controls skeletal homeostasis through effects on all three bone cell types 
(osteoblasts, osteoclasts, and osteocytes) [2], differentially in the four skeletal envelopes [4, 
5]. Estrogen depletion results in increased bone resorption coupled with an increase in global 
bone formation [6], the former in a greater magnitude thus resulting in a net bone loss. It 
increases osteocyte apoptosis [7-9], resulting in greater bone remodeling and resorption. 
Estrogen depletion is thought to directly affect the osteoblast through increases in apoptosis, 
oxidative stress, and NF-κB activity [2], and is also suspected to decrease sclerostin [10]. 
Moreover, the effects of estrogen depletion are bone envelope-specific [5, 11, 12]. 
Several animal models have been used in the study of postmenopausal osteoporosis. 
While the ovariectomized rat model is the most extensively used due to the low cost and ease 
of animal handling [13], it lacks the Haversian canal system present in human cortical bone. 
Moreover, ovariectomy does not significantly change cortical thickness as endosteal 
resorption is balanced by periosteal formation [13]. Nonhuman primates (monkeys) are not 
limited by any of these drawbacks, are genetically close to humans, have menstrual cycles 
and a menopause, and their immune system is comparable to humans; even though 
menopause occurs much later chronologically compared to humans, this can be compensated 
for through ovariectomy [13]. Their bones are characterized by increased turnover rates, 
osteopenia, and significant decreases in elastic modulus, shear modulus, failure shear stress, 
and failure torque [14, 15]. 
It is generally accepted that biological fluids are supersaturated with respect to 
apatites (the chemical phase of bone mineral), and mineralization is strictly regulated through 
appropriate inhibitors and nucleators that determine when, where, and how many mineral 
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crystallites will be formed. The purpose of the present study was to test the hypothesis that 
estrogen depletion alters this biological regulation of mineralization. We used Raman 
microspectroscopic analysis (affording spatial resolution of ~ 1 m) to investigate organic 
matrix quality (in particular glycosaminoglycan and pyridinoline content) in the osteoid 
(defined as a surface with evident calcein labels, 1µm distance from the mineralizing front, 
and for which the Raman spectra showed the presence of organic matrix but not mineral) and 
its correlation to the amount of freshly deposited mineral (surfaces with evident calcein 
labels, between the mineralizing front and the second label) in humeri from monkeys that 
were either SHAM-operated (SHAM) or ovariectomized (OVX). 
Identifying differences in the correlation between osteoid organic matrix quality and 
freshly deposited mineral content could further our understanding of how estrogen controls 
bone formation and mineralization. 
Materials & Methods 
Animals 
Details of the animals from which bone tissue was analyzed for the present study have 
been published previously [16]. All procedures were approved by the Animal Care and Use 
Committee of the Bowman Gray School of Medicine at Wake Forest University and 
conformed to institutional and NIH guidelines. In summary, natural habitat-derived adult (9 
years of age and weighing 2.77 ± 0.03 kg) female cynomolgus monkeys (Macaca 
fascicularis) were imported from Indonesia and quarantined for 3 months. Monkeys were 
screened radiographically to ensure absence of open growth plates and skeletal abnormalities. 
Double fluorochrome labels were given at 6 months (tetracycline HCl, 25 mg/kg, 
intravenously [iv]), 15 months (alizarin complexone, 20 mg/kg, iv), and before death at 18 
months (calcein, 10 mg/kg, iv) using a 1–12-1 schedule, with death 7 days after 
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administration of the final label [16]. In the present study, bone from SHAM-operated 
animals (SHAM; N=10) was examined and compared to bone from ovariectomized (OVX; N 
= 10) animals. Attention was focused on the calcein labels as they identify areas of the most 
recent bone formation (Fig. 1). 
Anatomical area selection criteria   
The following areas were analyzed at periosteal, osteonal, and endosteal surfaces with calcein 
fluorescent labels evident: 
a) Osteoid: defined as a surface with evident calcein labels, 1µm distance from the 
mineralizing front, and for which the Raman spectra showed the presence of organic 
matrix but not mineral.  
b) Youngest mineralized tissue (TA1): surfaces with evident calcein labels, between the 
mineralizing front and the second label.  
For each animal, nine different measurements were made at each of the areas outlined above, 
and averaged to create a single statistical data point. 
Raman analysis 
 Raman microspectroscopic analyses employed a Senterra (Bruker Optik GmbH) 
instrument. A continuous laser beam was focused onto the sample through a Raman 
fluorescence microscope (Olympus BX51, objective 50x) with an excitation of 785 nm (100 
mW) and a lateral resolution of ~0.6 µm. The Raman spectra were acquired from the bone 
surface, using a thermo-electric–cooled charge-coupled device (CCD) (Bruker Optik GmbH). 
All data analysis was done with the Opus Ident software package (OPUS 6.5, Bruker Optik 
GmbH). Once acquired, the Raman spectra were baseline corrected (rubber band, 5 
iterations) to account for fluorescence. The interlabel distance (IrLD) of the calcein double 
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labels was calculated from the fluorescence images obtained through the Raman microscope. 
Based on the acquired Raman spectra, the following parameters were calculated: 
I. The organic matrix content in the osteoid seam (osteoid consists of organic matrix and 
water) and at TA1 based on the ratio of integrated area of the Amide III (1215–1300 
cm
−1
) band to the spectral slice 494-509 cm
-1
 representative of PMMA [17]. 
II. The mineral content at the youngest tissue age (TA1), between the second calcein 
label and the mineral front, based on the ratio of the integrated area of the v2PO4 
(410–460 cm−1) band to the spectral slice 494-509 cm-1 representative of PMMA.  
III. The mineral maturity / crystallinity (MMC) was calculated from the inverse of the full 
width at half height v1PO4 peak [18]. 
IV. The relative glycosaminoglycans (GAG) content was calculated from the ratio of the 
integrated areas of the CH3 (1365–1390 cm
−1
) band representative of 
glycosaminoglycans [19], to the amide III (1215–1300 cm−1) band. In Raman 
spectroscopy, the spectral signature of proteoglycans is due to GAG chains.  
V. The relative pyridinoline content, calculated from the ratio of the Raman intensity at 
1660 cm
-1
 / the integrated area of the Amide I band (~1620-1700 cm
-1
) [20, 21].  
Statistical analysis 
Data are presented as mean and SD, or mean (where correlation analysis is involved). 
Between groups comparisons were made by unpaired t-tests. Significance was assigned to 
p<0.05. For visualization purposes, where individual data are shown, regression lines (either 
linear or exponential growth/decay) are also plotted, although comparisons are not based on 
any regression analysis. 
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Results 
Figure 1 shows an overview picture from a thin section of a SHAM monkey humerus 
showing all 3 fluorescent labels that were administered to the animals (a). For the purposes of 
the present study only osteons with evident calcein labels were considered (b). Fig. 1c shows 
three Raman spectra acquired in the area of TA1 (solid black line), osteoid (dashed black 
line), and PMMA away from the bone tissue (red dashed line). The peaks used in the present 
analysis have been labeled. As may be seen, the presence or absence of Amide I 
discriminates between areas of just PMMA and PMMA-embedded bone tissue. The presence 
of Amide I and Amide III coupled with the presence or absence of the v2PO4 peak allows the 
discrimination between osteoid and mineralized bone tissue. 
The advancement of the mineralizing front was faster in the OVX animals as 
suggested by the significantly greater interlabel distance compared to SHAM at osteonal 
(+35%, p < 0.05) and endosteal (+236%, p < 0.05) forming surfaces but not at periosteal ones 
(Fig. 2). 
No differences in organic matrix content between SHAM and OVX animals in either 
the osteoid or at TA1 were evident (Fig 3) at any of the three cortical surfaces (periosteal, 
osteonal, endosteal). The amount of mineral in the most newly formed bone (TA1) was also 
similar between the two animal groups (Fig 4, top row) at all cortical surfaces considered. We 
previously published that the GAG and Pyd content is not affected by estrogen depletion in 
either osteoid seam or at the youngest mineralized tissue [5]. The mineral maturity / 
crystallinity at TA1 was likewise statistically similar between SHAM and OVX animals (Fig. 
4, bottom row). 
When the osteoid seam GAG content was considered against the mineral content at 
TA1 (Fig. 5, top row), there was a significant negative correlation at periosteal (r = -0.65, p = 
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0.04), osteonal (r = -0.83, p = 0.005), and endosteal (r = -0.88, p = 0.001) surfaces in the 
SHAM animals, which was not evident in the OVX ones (periosteal r = -0.04, p = 0.9; 
osteonal r = -0.1, p = 0.79; endosteal r = -0.56, p = 0.09). 
When the osteoid seam Pyd content was considered against the mineral content at 
TA1 (Fig. 5, bottom row), there was a significant positive correlation at periosteal (r = 0.87, p 
= 0.0009), osteonal (r = 0.87, p = 0.002), and endosteal (r = 0.75, p = 0.02) surfaces in the 
SHAM animals, which was not evident in the OVX ones (periosteal r = 0.34, p = 0.36; 
osteonal r = -0.072, p = 0.84; endosteal r = 0.03, p = 0.93). 
Discussion 
Bone formation rate is not a singular entity but it encompasses rates of 
several concomitant yet partly independent from each other processes.  These include the rate 
of osteoblast differentiation, the rate of volumetric expansion, the rate of organic matrix 
synthesis per osteoblast (determining the density of the organic matrix in the newly created 
bone volume), the rate of organic matrix maturation (involving posttranslational 
modifications of proteins such as phosphorylation or dephosphorylation, collagen 
posttranslational modifications, addition or subtraction of proteoglycan GAG chains amongst 
others), the rate of mineral nucleation (formation of mineral nuclei in the organic matrix 
scaffold), the rate of mineral maturation (chemical transformation of the early mineral 
nuclei), and rate of mineral accumulation (how fast additional mineral is accumulated onto 
the initial mineral nuclei).  Not all of these rates are straight forward to measure in a 
biological system such as bone. 
Mineral apposition rate (MAR), measuring the average distance between two 
fluorescent labels administered at different times is commonly used to provide a measure of 
individual osteoblastic activity, and describe the rate of advancement of the mineralizing 
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front within a defined period. In the present study, the interlabel distance was significantly 
higher in the OVX animals compared to SHAM at osteonal and endosteal but not periosteal 
surfaces. This difference between cortical surfaces would be in agreement with previously 
published data on these animals highlighting the uniqueness of the periosteal surface 
(undergoing modeling) compared to osteonal and endosteal ones (undergoing remodeling) 
[5], although the contribution of the animal age (these animals are adult ones) and the 
possible decline in modeling rates can neither be excluded nor quantified in the present 
experiments.  
Raman microspectroscopy as employed in the present study analyzes a micro-volume 
of ~ 1x1x1 µm
3
. As such, the microvolumetric density of the organic matrix (organic matrix 
content within the micro-volume considered) in the osteoid seam as well as in the earliest 
deposited mineralized tissue (TA1) is similar in the SHAM and OVX animals, and the same 
holds for the mineral content at TA1. These results suggest that estrogen depletion does not 
alter the microvolumetric density of organic matrix in either the osteoid seam or the newly 
mineralized tissue, or the mineral in the newly mineralized tissue, but alters the rate of 
mineralization (based on IrLD). The lack of differences in mineral content between the 
animal groups at the youngest mineralized tissue employing the metric of mineral content 
normalized for PMMA content is in agreement with previously published results based on the 
more widely used metric of mineral / matrix ratio which led to the conclusion that ovarian 
hormone depletion does not affect the initial amount of mineral formed, but rather decelerates 
the rate of subsequent mineral accumulation [5]. The reason that we used the mineral/PMMA 
rather than the mineral / matrix ratio in the present work is that even though results are the 
same with both methods of expressing mineral content, the latter is sometimes confusing to 
the general readership as an increase in mineral / matrix ratio may be interpreted in several 
different ways. For example, in a previous study analyzing paired iliac crest biopsies from 
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healthy females before and immediately following menopause, the mineral / matrix ratio was 
increased post-menopause, not because there was an increase in mineral content but rather a 
decrease in organic matrix content, an observation consistent with previously published 
biochemical data [20]. With the exception of thermogravimetric analysis which directly and 
unequivocally measures mineral and organic matrix contents, all other analytical techniques 
measuring mineral content based on a surrogate (either calcium, or phosphate, or hydroxyl, or 
carbonate) thus are subject to potential contribution from the variable stoichiometry of bone 
apatite crystallites (biologically relevant apatites are highly substituted) which is dependent 
on age, tissue age, and health status. Raman spectroscopic analysis has minimal interference 
if any at all from the variability in the apatite stoichiometry as the same spectrum includes 
semi-quantitative information of the apatite crystallite stoichiometry in the mineral maturity / 
crystallinity metric [22, 23]. In the present study no significant differences existed between 
SHAM-operated and ovariectomized animals, further supporting the suggestion that the 
mineral content as measured in the present study has minimal if any contribution from 
variable mineral stoichiometry. 
Glycosaminoglycans are part of proteoglycans, and are responsible for the 
characteristic Raman band at ~ (1365–1390 cm−1) [19]. Even though it is not possible to 
identify individual proteoglycans by Raman analysis, one needs to bear in mind that in the 
major proteoglycans in bone - biglycan and decorin -chondroitin 4-sulfate constitutes about 
90% of the total GAG contentare [24]. Proteoglycans are known negative modulators of 
mineralization and bone turnover, and are present in micro- and nano-porous spaces such as 
osteocyte lacunae and canaliculi ensuring that these spaces remain mineral-free (the major 
proteoglycan present in these spaces is perlecan) [25-31]. Pyridinoline is a major enzymatic 
trivalent mineralizing type I collagen cross-link [32]. Enzymatic cross-links provide the 
fibrillar matrices with mechanical properties such as tensile strength and viscoelasticity [32, 
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33], and are important determinants of bone strength [34-37]. Mineralization of the collagen 
scaffold is dependent on fibril structure and organization, and it has been reported that the 
ratio of pyridinoline / deoxypyridinoline is associated with mineralization amount [38].  In 
the present work, there were significant correlations between the osteoid GAG (negative) and 
Pyd (positive) contents and the mineral content in the newly mineralized tissue in the SHAM 
group, which would be in general agreement with what is published in the literature 
concerning the relationship of these two organic matrix attributes and mineralization. On the 
other hand, there was no such correlation observed in the OVX group, even though there 
were no differences in GAG and Pyd content between SHAM and OVX animals, suggesting 
that the mechanism of regulation of mineral nucleation and accumulation by these two 
organic matrix characteristics is altered upon estrogen depletion, even though there were no 
differences in mineral content in the newly mineralized tissue between the two groups despite 
more rapid bone mineralization in OVX. 
The results of the present study show a significant correlation between osteoid seam 
GAG and Pyd content in recently formed bone in the SHAM but not the OVX animals. This 
observation holds at all three cortical surfaces. These results suggest that estrogen depletion 
alters the regulation of bone mineralization.   
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Figure Legends 
 
Figure 1: Overview of a humerus bone cross-section from a SHAM-operated animal (a) 
showing the calcein double labels amongst others; an osteon with calcein double labels 
evident (b). The osteoid seam was defined as a surface with evident calcein labels, 1µm 
distance from the mineralizing front, and for which the Raman spectra showed the presence 
of organic matrix but not mineral, while TA1 representing the youngest mineralized tissue 
was located at surfaces with evident calcein labels, between the mineralizing front and the 
second label. Typical Raman spectra obtained in the osteoid seam (dashed line) and at TA1 
(solid line) are shown in Fig. 1c, along with a spectrum obtained in an area of PMMA and 
devoid of any bone tissue, with the peaks of interest labeled. 
 
Figure 2: Interlabel distance (mean and SD) comparison between SHAM and OVX animals 
at the three different cortical surfaces. OVX animals exhibited significantly greater values at 
osteonal (+35%, p < 0.05) and endosteal (+236%, p < 0.05) surfaces, unlike periosteal ones.  
 
Figure 3: Organic matrix content in the osteoid seam (top row) and in the youngest 
mineralized tissue (bottom row) at the three different cortical surfaces. There were no 
differences between the SHAM-operated and the OVX animals. 
 
Figure 4: Mineral content in the youngest mineralized tissue (between the second calcein 
fluorescent label and the mineralizing front) at the three different cortical surfaces (top row). 
There were no differences between the SHAM-operated and the OVX animals. Similarly, no 
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significant differences between the two animal groups in mineral maturity / crystallinity were 
evident (bottom row). 
 
Figure 5: Top row: correlations between osteoid GAG and youngest mineral content at the 
three cortical surfaces. Significant negative correlations were evident in the SHAM animals 
at all three (periosteal r = -0.65, p = 0.04; osteonal r = -0.83, p = 0.005; endosteal r = -0.88, p 
= 0.001), unlike the OVX ones. Bottom row: correlations between osteoid Pyd and youngest 
mineral content at the three cortical surfaces. Significant correlations were evident in the 
SHAM animals at all three (periosteal r = 0.87, p = 0.0009; osteonal r = 0.87, p = 0.002; 
endosteal r = 0.75, p = 0.02), unlike the OVX ones. 
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Highlights 
i.  Earliest deposited mineral content decreases with osteoid glycosaminoglycan content and 
increases with osteoid pyridinoline content in SHAM operated monkeys. 
 
ii. There are no significant correlations between earliest deposited mineral content and 
osteoid glycosaminoglycan and pyridinoline content in ovariectomized monkeys. 
 
iii. These results suggest that estrogen depletion alters the mineralization regulation 
ACCEPTED MANUSCRIPT
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
